Comorbid parasomnias in narcolepsy and idiopathic hypersomnia: more REM than NREM parasomnias
- PMID: 34984974
- PMCID: PMC9059608
- DOI: 10.5664/jcsm.9862
Comorbid parasomnias in narcolepsy and idiopathic hypersomnia: more REM than NREM parasomnias
Abstract
Study objectives: To assess the frequency, determinants, and clinical impact of clinical rapid eye movement (REM) and non-REM (NREM) parasomnias in adult patients with narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and idiopathic hypersomnia compared with healthy controls.
Methods: Familial and past and current personal parasomnias were assessed by questionnaire and medical interviews in 710 patients (220 NT1, 199 NT2, and 221 idiopathic hypersomnia) and 595 healthy controls.
Results: Except for sleep-related eating disorder, current NREM parasomnias were rare in all patient groups and controls. Sleep-related eating disorder was more frequent in NT1 patients (7.9% vs 1.8% in NT2 patients, 2.1% in patients with idiopathic hypersomnia, and 1% in controls) and associated with disrupted nighttime sleep (odds ratio = 3.9) and nocturnal eating in full awareness (odds ratio = 6.9) but not with sex. Clinical REM sleep behavior disorder was more frequent in NT1 patients (41.4%, half being violent) than in NT2 patients (13.2%) and affected men more often than women (odds ratio = 2.4). It was associated with disrupted nighttime sleep, depressive symptoms, and antidepressant use. Frequent (> 1/week) nightmares were reported by 39% of patients with NT1, 29% with NT2, and 27.8% with idiopathic hypersomnia (vs 8.3% in controls) and were associated with depressive symptoms in narcolepsy. No parasomnia (except sleep-related hallucinations) worsened daytime sleepiness.
Conclusions: In patients with central disorders of hypersomnolence, comorbid NREM parasomnias (except for sleep-related eating disorder) are rare and do not worsen sleepiness. In contrast, REM parasomnias are prevalent (especially in NT1) and are associated with male sex, disrupted nighttime sleep, depressive symptoms, and antidepressant use.
Citation: Leu-Semenescu S, Maranci J-B, Lopez R, et al. Comorbid parasomnias in narcolepsy and idiopathic hypersomnia: more REM than NREM parasomnias. J Clin Sleep Med. 2022;18(5):1355-1364.
Keywords: REM sleep behavior disorder; antidepressants; idiopathic hypersomnia; narcolepsy; nightmare disorder; sleep talking; sleep terrors; sleep-related eating disorder; sleepwalking.
© 2022 American Academy of Sleep Medicine.
Conflict of interest statement
All authors have seen and approved the manuscript. Work for this study was performed at the Sleep Disorders Unit, Pitié-Salpêtrière University Hospital, Paris, France; Sleep Disorders Center, Department of Neurology, Gui-de-Chauliac Hospital, CHU Montpellier; and the Sleep Disorder Unit, Mondor Hospital, Créteil. This study was funded by PHRC AOM07-138 from the French Health Ministry (promoter: Assistance Publique-Hôpitaux de Paris; principal investigator: I.A.). Isabelle Arnulf received an honorarium from UCB Pharma for speaking engagements and was a consultant for Idorsia Pharma and Ono Pharma. These financial disclosures are unrelated to the present study and topic. Yves Dauvilliers received funds for seminars, board engagements, and travel to conferences from UCB Pharma, Jazz Pharma, Theranexus, Flamel, and Bioprojet Pharma. Régis Lopez received funds for speaking from UCB Pharma and Shire Pharma. Lucie Barateau and Smaranda Leu-Semenescu received funds for travel to conferences from UCB Pharma. Patricia Franco had speaking engagements with UCB Pharma and was a consultant for Biocodex Pharma. Michel Lecendreux has received consulting fees and honoraria and has been on advisory boards for Bioprojet Pharma, Jazz Pharma, UCB Pharma, and Alvadel Pharma. Ana Gales has received honoraria for speaking engagements from EISAI Pharma. The other authors report no conflicts of interest.
Figures

Similar articles
-
Sleeping through a pandemic: impact of COVID-19-related restrictions on narcolepsy and idiopathic hypersomnia.J Clin Sleep Med. 2022 Jan 1;18(1):255-263. doi: 10.5664/jcsm.9556. J Clin Sleep Med. 2022. PMID: 34314345 Free PMC article.
-
Stability of nocturnal wake and sleep stages defines central nervous system disorders of hypersomnolence.Sleep. 2021 Jul 9;44(7):zsab021. doi: 10.1093/sleep/zsab021. Sleep. 2021. PMID: 33512510 Free PMC article.
-
Test-Retest Reliability of the Multiple Sleep Latency Test in Central Disorders of Hypersomnolence.Sleep. 2017 Dec 1;40(12). doi: 10.1093/sleep/zsx164. Sleep. 2017. PMID: 29099966
-
Comparative polysomnography parameters between narcolepsy type 1/type 2 and idiopathic hypersomnia: A systematic review and meta-analysis.Sleep Med Rev. 2022 Jun;63:101610. doi: 10.1016/j.smrv.2022.101610. Epub 2022 Feb 18. Sleep Med Rev. 2022. PMID: 35278894
-
Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline.J Clin Sleep Med. 2021 Sep 1;17(9):1881-1893. doi: 10.5664/jcsm.9328. J Clin Sleep Med. 2021. PMID: 34743789 Free PMC article.
Cited by
-
Treating narcolepsy-related nightmares with cognitive behavioural therapy and targeted lucidity reactivation: A pilot study.J Sleep Res. 2025 Jun;34(3):e14384. doi: 10.1111/jsr.14384. Epub 2024 Oct 22. J Sleep Res. 2025. PMID: 39438131 Free PMC article. Clinical Trial.
-
Behavior, motivational interviewing, eating disorders, and obesity management technologies: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.Obes Pillars. 2022 Mar 24;2:100014. doi: 10.1016/j.obpill.2022.100014. eCollection 2022 Jun. Obes Pillars. 2022. PMID: 37990715 Free PMC article.
-
Diagnostic challenges and burden of idiopathic hypersomnia: a systematic literature review.Sleep Adv. 2024 Aug 16;5(1):zpae059. doi: 10.1093/sleepadvances/zpae059. eCollection 2024. Sleep Adv. 2024. PMID: 39211350 Free PMC article.
-
Families of adults with idiopathic hypersomnia and narcolepsy: psychosocial impact and contribution to symptom management.J Clin Sleep Med. 2025 Apr 1;21(4):683-694. doi: 10.5664/jcsm.11526. J Clin Sleep Med. 2025. PMID: 39745457
-
Current evidence and future perspectives in the exploration of sleep-related eating disorder-a systematic literature review.Front Psychiatry. 2024 May 30;15:1393337. doi: 10.3389/fpsyt.2024.1393337. eCollection 2024. Front Psychiatry. 2024. PMID: 38873533 Free PMC article.
References
-
- Sateia MJ . International Classification of Sleep Disorders-Third Edition: highlights and modifications . Chest. 2014. ; 146 ( 5 ): 1387 – 1394 . - PubMed
-
- Barateau L , Liblau R , Peyron C , Dauvilliers Y . Narcolepsy type 1 as an autoimmune disorder: evidence, and implications for pharmacological treatment . CNS Drugs. 2017. ; 31 ( 10 ): 821 – 834 . - PubMed
-
- Winkelman JW . Sleep-related eating disorder and night eating syndrome: sleep disorders, eating disorders, or both? Sleep. 2006. ; 29 ( 7 ): 876 – 877 . - PubMed
-
- Arnulf I , Uguccioni G , Gay F , et al. . What does the sleeping brain say? syntax and semantics of sleep talking in healthy subjects and in parasomnia patients . Sleep. 2017. ; 40 ( 11 ): zsx159 . - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous